Citalopram versus other selective serotonin-reuptake inhibitors

被引：2
|
作者：
Thomas, KV [1 ]
Holimon, TD [1 ]
机构：
[1] Univ Tennessee, Coll Pharm, Drug Informat Ctr, Dept Pharm Practice & Pharmacoecon, Memphis, TN 38163 USA
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 1999年 / 56卷 / 21期
关键词：
D O I：
10.1093/ajhp/56.21.2242
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2242 / 2244
页数：3
相关论文
共 50 条
  • [41] Hypoglycemia and Voluntary Overdose of Selective Serotonin Reuptake Inhibitors (Citalopram and Venlafaxine)
    Torrents, R.
    Brun, R.
    Schmitt, C.
    Boulamery, A.
    Simon, N.
    de Haro, L.
    ANNALES FRANCAISES DE MEDECINE D URGENCE, 2014, 4 (05): : 332 - 333
  • [42] Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children
    Klein-Schwartz, Wendy
    Benson, Blaine E.
    Lee, Samantha C.
    Litovitz, Toby
    CLINICAL TOXICOLOGY, 2012, 50 (05) : 418 - 423
  • [43] Selective Serotonin-reuptake inhibitors (SSRI) in treatment of child and adolescent psychiatry disorders
    Stilke, D
    ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 1997, 25 (02): : 106 - 116
  • [44] Lack of clinical evidence for potential interaction between isoniazid and selective serotonin-reuptake inhibitors
    Stockley, IH
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (18) : 2217 - 2217
  • [45] Chlorpheniramine, selective serotonin-reuptake inhibitors (SSRIs) and over-the-counter (OTC) treatment
    Hellbom, E
    MEDICAL HYPOTHESES, 2006, 66 (04) : 689 - 690
  • [46] Selective Serotonin-Reuptake Inhibitors and Risks of Persistent Fetal Circulation and Pulmonary Hypertension in the Newborn
    Kieler, Helle
    Furu, Kari
    Gissler, Mika
    Noergaard, Mette
    Valdimarsdottir, Unnur
    Haglund, Bengt
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S10 - S10
  • [47] Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline
    Stahl, SM
    BIOLOGICAL PSYCHIATRY, 2000, 48 (09) : 894 - 901
  • [48] Maternal Use of Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
    Alwan, S.
    Bandoli, G.
    Chambers, C. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (01) : 34 - 41
  • [49] CLINICAL PHARMACOKINETICS OF CITALOPRAM AND OTHER SELECTIVE SEROTONERGIC REUPTAKE INHIBITORS (SSRI)
    BAUMANN, P
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1992, 6 : 13 - 20
  • [50] First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects
    Louik, Carol
    Lin, Angela E.
    Werler, Martha M.
    Hernandez-Diaz, Sonia
    Mitchell, Allen A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (26): : 2675 - 2683
12345